Feb 5 (Reuters) - CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for lower-cost alternatives in some of its preferred drug lists, starting April 1. Its ...
(Corrects paragraph 5 in February 5 story to say 2025 Prolia sales were $4.4 billion, not $1.05 billion) Feb 5 (Reuters) – CVS Health said on Thursday it would swap out Amgen and Eli Lilly’s bone ...
Walmart hits $1 trillion in market value for the first time Palantir shares gain after quarterly results Obesity drugmakers drop on Novo Nordisk's outlook warning S&P 500 -0.84%, Nasdaq -1.43%, Dow -0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results